FNY Managed Accounts’s Boston Scientific BSX Stock Holding History

FNY Managed Accounts’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-412	Closed	-$10K	–	625
2017 Q4	$10K	Sell	412 -136	-25%	-$3.75K	0.01%	199
2017 Q3	$15K	Buy	+548	New	+$15.1K	0.02%	391
2015 Q4	–	Sell	-838	Closed	-$13.8K	–	198
2015 Q3	$13.8K	Sell	838 -555	-40%	-$9.49K	0.04%	247
2015 Q2	$24.7K	Sell	1,393 -1,107	-44%	-$19.8K	0.03%	200
2015 Q1	$44.4K	Buy	+2,500	New	+$39.5K	0.04%	140

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

FNY Managed Accounts's BSX Position: Q1 2018 in Review

FNY Managed Accounts sold out of Boston Scientific (BSX) in Q1 2018, closing a stake of 412 shares — an estimated $10K sold.

FNY Managed Accounts first reported a position in BSX in Q1 2015 and held it in 5 quarters. The position peaked at $44.4K in Q1 2015. 634 funds tracked by Wall St. Rank hold BSX as of Q1 2018.

FNY Managed Accounts reported no remaining Boston Scientific position as of Q1 2018 after selling out during the quarter.
FNY Managed Accounts sold 412 Boston Scientific shares in Q1 2018, an estimated $10K.
FNY Managed Accounts first reported a position in Boston Scientific in Q1 2015 and held it in 5 quarters.
FNY Managed Accounts's Boston Scientific position peaked at $44.4K in Q1 2015.
634 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.